- Points to consider on implications of Coronavirus disease (COVID-19) on methodological aspects of ongoing clinical trials
- Overview of comments received on ‘Points to consider on implications of Coronavirus
disease 5 (COVID-19) on methodological aspects of ongoing clinical trials (EMA/158330/2020) - Draft responses to stakeholder comments on the Points to consider on the impact of COVID-19 on methodological aspects of ongoing clinical trials..
